Basophil FceRI expression-A management tool in anti-IgE treatment of allergic asthma.
Sune Leisgaard Mørck RubakNadja Lindberg BonneBritta Eilertsen HjerrildHans Jürgen HoffmannPublished in: Pediatric pulmonology (2024)
This cohort study demonstrates a promising method, measuring basophil allergen sensitivity and in particular blood basophil FceRI density, concerning the monitoring of anti-IgE treatment in different clinical situations. There are no randomized controlled trials evaluating this method in clinical settings.